Halothane

This classification denotes an anesthetic agent with the molecular formula C2HBrClF3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UQT9G45D1P, chemically known as 2,2,2-trifluoro-1-chloro-1-bromoethane but generally known as halothane, which bears US NIH Compound Identifier 3562. European Medicines Agency schedules Halothane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08009MIG. The term HALOTHANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules halothane in its Anatomical Therapeutic Chemical (ATC) Classification. HALOTHANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HALOTHANE remains the US FDA Preferred Term for this commodity. Halothane bears US NLM identifiers UMLS ID C0018549 and NCI Concept Code C47554. SMILES: BRC(CL)C(F)(F)F.